We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Test Predicts Alzheimer's with Exceptional Accuracy

By LabMedica International staff writers
Posted on 22 Aug 2011
The latest blood test for Alzheimer's disease (AD) is extremely accurate at identifying the disease and can perhaps detect it even before symptoms such as memory loss develop.

Human protein microarrays were used to characterize the differential expression of serum autoantibodies in AD and nondemented control (NDC) groups, to identify potential diagnostic biomarkers for AD.

Scientists from the University of Medicine and Dentistry of New Jersey, (Stratford, NJ, USA), collected serum samples from 50 AD subjects, 40 NDC controls (NDC), 30 breast cancer (BC) patients, and 29 from individuals with Parkinson's disease (PD). Autoantibodies in human sera were identified using ProtoArray Human Protein Microarrays (Invitrogen, Carlsbad, CA, USA) each containing 9,486 unique human protein antigens.

Overall, the tests identified 96% of those with Alzheimer's correctly. It correctly identified 92.5% of those who did not have Alzheimer's. The team was able to make an inventory of 10 antibody biomarkers needed to detect Alzheimer's disease. The relative noninvasiveness, low cost, and dynamism of protein microarrays make a diagnostic of this kind well-suited for incorporation into routine health care. The team's hope is that with a diagnostic such as this, accessible early screening methods can be established so that patients will be better positioned to avail themselves of effective therapies as they arise.

Robert Nagele, PhD, who developed the test, said, "This is a simple test that has high accuracy and can be run from a single drop of blood. Brain cells die and when they die, they pop; they explode, like a water balloon breaking. Your body makes antibodies against the cell debris. We believe that happens so it can facilitate the cleanup of the cell debris. Many of these are related to the presence of the disease.” The study was published on August 3, 2011, in the online journal Public Library of Science ONE.

Related Links:
University of Medicine and Dentistry of New Jersey
Invitrogen



New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Clinical Sample Concentrator
QIAamp DSP Virus Kit
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS

Latest Molecular Diagnostics News

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

WHO Approves First Mpox Diagnostic Test for Emergency Use

Clinical Digital PCR System for Oncology Testing Delivers Highly Accurate Diagnostic Results